Read More >>
NEW DELHI: The health ministry may soon ban over 300 fixed-dose combinations (FDCNSE -1.99 %) medicines, accepting recommendations of a sub-committee of India’s apex drug advisory body. The move, which is expected to impact top MNCs such as AbbottNSE 1.87 % as well as domestic players such as PiramalNSE -1.98 %, Macleods, Cipla and Lupin among others, could be challenged in the courts once again.
If the initial draft ban notification that ET has viewed are implemented, the ban would cover popular cough syrups, pain killers and flu medicines like Phensedyl, Saridon and D’Cold Total. The draft lists out 343 FDCs that the ministry plans to ban manufacture, sale and distribution of and has been prepared based on recommendations of the Drug Technical Advisory Board (DTAB).